A Clinical Trial to Compare Lasotronix Alone or in Combination With CPP-ACP to Treat DH
A Clinical Study to Evaluate the Effectiveness of Casein Phosphopeptide, Amorphous Calcium Phosphate Paste (CPP-ACP) Used Alone or in Combination With Lasotronix (Diode Laser) to Treat Dentin Hypersensitivity
Dow University of Health Sciences
120 participants
May 12, 2024
INTERVENTIONAL
Conditions
Summary
Dentin hypersensitivity (DH) is defined as sharp pain of a shorter duration arise from exposed dentin in response to several chemicals and thermal or tactile stimuli that cannot be ascribed to other dental defects". DH has a prevalence rate ranging from 1.3% to 92.1%, commonly affecting old ages. The use of laser has opened new dimensions in the treatment of DH. To the author's knowledge, not much research work has been conducted using LASOTRONIX as a treatment modality with CPP-ACP. Therefore, this research aims to determine the effectiveness of Casein phospho peptide paste (CPP-ACP) used alone or combined with a diode laser (LASOTRONIX).
Eligibility
Inclusion Criteria2
- Patients of either gender, with ages between 25-65 years
- should have at least more than one hypersensitive and vital tooth without any carious lesion or defective restoration
Exclusion Criteria5
- History of desensitizing therapy on the affected tooth/teeth in last six months (use of desensitizing toothpaste)
- use of antibiotics /analgesic/anti-inflammatory drugs
- history of smoking
- pregnancy
- those who are not willing to participate or give follow-ups
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
CPP-ACP paste will be applied on exposed area
Lasotronix will be applied following its protocol
This group will receive the combination of above two treatments
this will be a control group
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06463938